Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $25,000 Today

NetEase (NASDAQ:NTES) has outperformed the market over the past 15 years by 17.64% on an annualized basis producing an average annual return of 23.84%. Currently, NetEase has a market capitalization of $61.32 billion.

Benzinga

$1000 Invested In NVIDIA 15 Years Ago Would Be Worth This Much Today

NVIDIA (NASDAQ:NVDA) has outperformed the market over the past 15 years by 16.22% on an annualized basis producing an average annual return of 22.42%. Currently, NVIDIA has a market capitalization of $378.98 billion.

Benzinga

Analyst Ratings for Texas Instruments

Texas Instruments (NASDAQ:TXN) has observed the following analyst ratings within the last quarter:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Analyst Ratings for Duck Creek Technologies

Duck Creek Technologies (NASDAQ:DCT) has observed the following analyst ratings within the last quarter:

Benzinga

Lululemon Athletica Whale Trades For June 30

Someone with a lot of money to spend has taken a bearish stance on Lululemon Athletica (NASDAQ:LULU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

$100 Invested In Nasdaq 20 Years Ago Would Be Worth This Much Today

Nasdaq (NASDAQ:NDAQ) has outperformed the market over the past 20 years by 5.01% on an annualized basis producing an average annual return of 12.11%. Currently, Nasdaq has a market capitalization of $25.13 billion.

Benzinga

Peering Into Old Dominion Freight Line's Recent Short Interest

Old Dominion Freight Line's (NASDAQ:ODFL) short percent of float has risen 7.87% since its last report. The company recently reported that it has 3.75 million shares sold short, which is 3.84% of all regular shares that are available for trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Why Akebia Therapeutics Stock Is Soaring After Hours

Akebia Therapeutics Inc (NASDAQ: AKBA) shares are surging in Thursday's after-hours session after the company executed an agreement to terminate its Vadadustat collaboration and license agreements with Otsuka Pharmaceutical.

Benzinga

Purecycle Technologies Shares Slide On Leadership Changes Announcement

Purecycle Technologies Inc (NASDAQ:PCT) has promoted Dustin Olson, current Chief Operating Officer and Chief Manufacturing Officer, to the role of CEO, along with becoming a member of the board, effective August 5, 2022. Mr. Olson succeeds Mike Otworth, who will resign to return to Innventure, a company he helped found. Dustin Olson…

Benzinga

Benzinga Asks: Will Elon Musk Have More Than 125 Million Twitter Followers At The End Of 2022? 40% Said This

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk is the world’s richest person and one of the most-followed people on Twitter Inc (NYSE: TWTR), just passing the 100 million follower milestone on the

Benzinga

Accolade Shares Slip After Q1 Results, Guides Q2 Revenue Below Consensus

Accolade Inc (NASDAQ:ACCD) reported first-quarter revenue growth of 44% year-over-year to $85.5 million, beating the consensus of $81.97 million. EPS was $(4.92), compared to $(0.84) in 1Q22. Adjusted gross profit increased by 63% Y/Y to $39 million, and margin expanded by 545 bps to 45.6%. Adjusted EBITDA loss widened to $(15.4) million…

Benzinga

What Joe Rogan, Elon Musk Have In Common: Their 2024 Presidential Pick

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk and Spotify Technology SA (NYSE: SPOT) podcaster Joe Rogan are two of the most influential figures in pop culture today.

Benzinga

Which Mega-Cap Tech Stock Would You Buy First: Microsoft, Apple Or Amazon?

CNBC ran a survey Thursday asking investors which technology stock they would buy first at current levels. Here's a look at the results.

Benzinga

What's Going On With PayPal Stock Today?

PayPal Holdings Inc (NASDAQ: PYPL) shares are trading lower Thursday amid overall market weakness as investors continue to digest inflation concerns, Fed rate hikes and macro uncertainty. Concerns surrounding a potential economic slowdown have also weighed on growth stocks.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Is Bed Bath & Beyond Worth Only $2 Per Share? Here's What 3 Analysts Are Saying

Retailer Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported first-quarter earnings and the departure of its CEO Mark Tritton on Wednesday.

Benzinga

What's Going On With Tesla Shares Today?

Tesla Inc (NASDAQ: TSLA) shares are trading lower by 1.26% to $676.86 Thursday afternoon. Shares of auto and auto manufacturers companies are trading lower during Thursday’s trading session after data showed a slowdown in U.S. consumer spending in May.

Benzinga

J B Hunt Accelerates Overseas Transport Of New Containers

J B Hunt Transport Services Inc’s (NASDAQ: JBHT) cargo vessel Johnelle has docked at the Port of Everett in Washington, with more than 250 new containers reserved for the expansion of the intermodal fleet.

Benzinga

What's Going On With Apple Shares Falling Today?

Apple Inc (NASDAQ: AAPL) shares are trading lower by 1.64% to $136.95 Thursday afternoon. Shares of retail and consumer discretionary companies are trading lower during Thursday’s trading session after data showed a slowdown in U.S. consumer spending in May.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Nasdaq Down 100 Points; Angion Biomedica Shares Plummet

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.

Benzinga

This Analyst Thinks Blueprint Medicines' Non-Dilutive Funding 'Deflates M&A Speculation'

Today Blueprint Medicines Corp (NASDAQ:BPMC) announced strategic financing agreements with Sixth Street and Royalty Pharma Plc (NASDAQ:RPRX) for up to $1.25 billion, including $575 million upfront upon deal closure. SVB Securities thinks the terms of the deals are fairly valued on the Sixth Street portion and favorable for Blueprint Medicines on the Royalty Pharma portion. "In addition,…

Benzinga

$1000 Invested In Micron Technology 15 Years Ago Would Be Worth This Much Today

Micron Technology (NASDAQ:MU) has outperformed the market over the past 15 years by 3.76% on an annualized basis producing an average annual return of 9.99%. Currently, Micron Technology has a market capitalization of $62.67 billion.

Benzinga

This Analyst Says US Government Buying More COVID-19 Vaccines At Higher Prices

Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced a new COVID-19 vaccine supply agreement with the U.S. government. SVB Leerink says that the new contract implies the price per Comirnaty dose is ~$30.50. Comirnaty U.S. pricing per dose has increased from $19.50 (2020 contracts), to $24 (+23%; 2021 contract), and now to ~$30.50 (+27%). The analysts…

Benzinga

Middleby Expands Offerings In Ice - Read How

Middleby Corp (NASDAQ:MIDD) has acquired Icetro, a maker of ice, soft serve, and slush machines used worldwide in commercial food service. Deal terms were not disclosed. Icetro has annual sales of ~$40 million and is headquartered in South Korea, with U.S. operations based in Anaheim, California. The acquisition furthers MIDD's Asian manufacturing…

Benzinga

Where Brilliant Earth Group Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on Brilliant Earth Group (NASDAQ:BRLT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Analyst Ratings for Xcel Energy

Analysts have provided the following ratings for Xcel Energy (NASDAQ:XEL) within the last quarter:

1 … 335 336 337 338

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.